Skip to content
← Back to this collection

PUBLICATIONS · 21131038

Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet
Publication date
2010 Dec 11
First author
Parker C

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2010 Dec 11;376(9757):1968-70. doi: 10.1016/S0140-6736(10)62194-0.
    note
    Source null
    related pmid
    21131040
    relationship
    Comment in
  2. citation
    Nat Rev Clin Oncol. 2011 Mar;8(3):123. doi: 10.1038/nrclinonc.2011.12.
    note
    Source null
    related pmid
    21480558
    relationship
    Comment in

Authors and identifiers

  1. name
    Parker C
    type
    Author
  2. name
    Waters R
    type
    Author
  3. name
    Leighton C
    type
    Author
  4. name
    Hancock J
    type
    Author
  5. name
    Sutton R
    type
    Author
  6. name
    Moorman AV
    type
    Author
  7. name
    Ancliff P
    type
    Author
  8. name
    Morgan M
    type
    Author
  9. name
    Masurekar A
    type
    Author
  10. name
    Goulden N
    type
    Author
  11. name
    Green N
    type
    Author
  12. name
    Révész T
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Parker C
    type
    Author
  2. name
    Waters R
    type
    Author
  3. name
    Leighton C
    type
    Author
  4. name
    Hancock J
    type
    Author
  5. name
    Sutton R
    type
    Author
  6. name
    Moorman AV
    type
    Author
  7. name
    Ancliff P
    type
    Author
  8. name
    Morgan M
    type
    Author
  9. name
    Masurekar A
    type
    Author
  10. name
    Goulden N
    type
    Author
  11. name
    Green N
    type
    Author
  12. name
    Révész T
    type
    Author
bibliography ids
  1. nci-bib-8a7e88331f5490b892417288
book metadata
content sha256
c161f764d61472d7ffb71e13936d4b115f2786705d81fb2f0583a5b6014a4374
document type
citation
dois
  1. 10.1016/S0140-6736(10)62002-8
electronic publication date
display
2010 Dec 3
precision
day
year
2010
evidence scope
bibliographic_metadata_only
id
pubmed:21131038
immutable id
pubmed:21131038@c161f764d61472d7ffb71e13936d4b115f2786705d81fb2f0583a5b6014a4374
journal
abbreviation
Lancet
issn electronic
1474-547X
issn print
0140-6736
issue
9757
name
Lancet (London, England)
nlm unique id
2985213R
pages
2009-17
volume
376
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2010 Dec 11;376(9757):1968-70. doi: 10.1016/S0140-6736(10)62194-0.
    note
    Source null
    related pmid
    21131040
    relationship
    Comment in
  2. citation
    Nat Rev Clin Oncol. 2011 Mar;8(3):123. doi: 10.1038/nrclinonc.2011.12.
    note
    Source null
    related pmid
    21480558
    relationship
    Comment in
outcomes validated
false
pmid
21131038
provenance
batch id
edef4b7f1a2a505cd5a9
provider
NCBI PubMed ESummary
record sha256
9125ec36866112f14f8b866c0d02f96bf708b84853bc13495e316e8b36b651a1
response sha256
d2d0fd7c34783716c953156f8a1da1b7b36c4823b416656eca04a1e69e03a295
retrieved at
2026-09-09T23:46:38.027615+00:00
publication date
display
2010 Dec 11
precision
day
year
2010
publication types
  1. Comparative Study
  2. Journal Article
  3. Randomized Controlled Trial
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/21131038/
title
Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial.

Preserved source evidence · Not medical advice